TY - JOUR
T1 - Randomized controlled clinical trial of "Virtual house calls" for Parkinson disease
AU - Dorsey, E. Ray
AU - Venkataraman, Vinayak
AU - Grana, Matthew J.
AU - Bull, Michael T.
AU - George, Benjamin P.
AU - Boyd, Cynthia M.
AU - Beck, Christopher A.
AU - Rajan, Balaraman
AU - Seidmann, Abraham
AU - Biglan, Kevin M.
PY - 2013/5
Y1 - 2013/5
N2 - Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention : Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures : The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11).Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P =.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4- point improvement; P =.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
AB - Importance: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. Objective: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. Design: A 7-month, 2-center, randomized controlled clinical trial. Setting: Patients' homes and outpatient clinics at 2 academic medical centers. Participants: Twenty patients with Parkinson disease with Internet access at home. Intervention : Care from a specialist delivered remotely at home or in person in the clinic. Main Outcome Measures : The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. Results: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n=9) or in-person care (n=11).Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P =.99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4- point improvement; P =.61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. Conclusion and Relevance: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable.
UR - http://www.scopus.com/inward/record.url?scp=84877735335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877735335&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2013.123
DO - 10.1001/jamaneurol.2013.123
M3 - Article
C2 - 23479138
AN - SCOPUS:84877735335
SN - 2168-6149
VL - 70
SP - 565
EP - 570
JO - JAMA Neurology
JF - JAMA Neurology
IS - 5
ER -